(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 4.83% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.07%.
Elanco Animal Health's revenue in 2026 is $4,893,000,000.On average, 18 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,547,692,322,883, with the lowest ELAN revenue forecast at $2,433,817,817,959, and the highest ELAN revenue forecast at $2,630,600,953,661. On average, 18 Wall Street analysts forecast ELAN's revenue for 2027 to be $2,684,042,059,042, with the lowest ELAN revenue forecast at $2,534,706,633,725, and the highest ELAN revenue forecast at $2,795,419,316,051.
In 2028, ELAN is forecast to generate $2,813,898,950,622 in revenue, with the lowest revenue forecast at $2,635,595,449,491 and the highest revenue forecast at $2,961,236,577,607.